PUBLISHER: GlobalData | PRODUCT CODE: 1663698
PUBLISHER: GlobalData | PRODUCT CODE: 1663698
Reconstruction Meshes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.
Reconstruction Meshes are surgically implantable woven sheets that are used to repair or support organs and other tissues. The meshes are made either from synthetic material and/or bioengineered from animal tissues. Reconstruction Meshes are generally available in multiple sizes, thicknesses, and pore sizes, however for this market model the meshes are segmented based on the materials used to make them.
The market for breast reconstruction is mainly driven by patients with breast cancer, as that is the most common type of cancer in women. Many breast cancer patients undergo single or double mastectomies, thus requiring breast reconstruction. This population is expected to grow as the global female population ages and the prevalence of mastectomies increases. Breast reconstruction improves the quality of life of patients, such that the number of reconstruction Interventions is expected to increase.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Reconstruction Meshes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Allergan Aesthetics, W. L. Gore & Associates Inc, MTF Biologics, Surgalign Holdings Inc, Coloplast A/S, Ethicon Inc, Boston Scientific Corp, CR Bard Inc, Integra LifeSciences Holdings Corp, pfm medical ag, Baxter International Inc, LifeNet Health Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -